annb0t
Top 20
Key Insights
Neuren Pharmaceuticals' estimated fair value is AU$37.87 based on 2 Stage Free Cash Flow to Equity Current share price of AU$20.27 suggests Neuren Pharmaceuticals is potentially 46% undervalued Analyst price target for NEU is AU$28.56 which is 25% below our fair value estimate
In this article we are going to estimate the intrinsic value of Neuren Pharmaceuticals Limited (ASX:NEU) by taking the forecast future cash flows of the company and discounting them back to today's value. On...
>>> Read more: Are Investors Undervaluing Neuren Pharmaceuticals Limited (ASX:NEU) By 46%?
Neuren Pharmaceuticals' estimated fair value is AU$37.87 based on 2 Stage Free Cash Flow to Equity Current share price of AU$20.27 suggests Neuren Pharmaceuticals is potentially 46% undervalued Analyst price target for NEU is AU$28.56 which is 25% below our fair value estimate
In this article we are going to estimate the intrinsic value of Neuren Pharmaceuticals Limited (ASX:NEU) by taking the forecast future cash flows of the company and discounting them back to today's value. On...
>>> Read more: Are Investors Undervaluing Neuren Pharmaceuticals Limited (ASX:NEU) By 46%?
